Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 10, 2026, 9:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Vardenafil Clear all

Conditions: Glioma, Brain Neoplasms, Brain Metastasis
Interventions: Vardenafil, Carboplatin; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Erectile Dysfunction
Interventions: Levitra (Vardenafil, BAY38-9456), Sildenafil, Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 25 Years to 64 Years · Male only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 18
States / cities: Phoenix, Arizona • Tempe, Arizona • Beverly Hills, California + 15 more

Conditions: Erectile Dysfunction
Interventions: Placebo, Levitra (Vardenafil, BAY38-9456); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 12
States / cities: Phoenix, Arizona • Beverly Hills, California • Laguna Hills, California + 9 more

Conditions: Pulmonary Arterial Hypertension
Interventions: Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere dry powder inhaler (AOS DPI); Combination Product
Lead sponsor: Respira Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 26
States / cities: Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 22 more

Conditions: Erectile Dysfunction, Sexual Dysfunction, Physiological
Interventions: Levitra (Vardenafil, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 11
States / cities: Laguna Hills, California • Jeffersonville, Indiana • Des Moines, Iowa + 8 more

Conditions: Erectile Dysfunction
Interventions: LEVITRA (vardenafil), placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 65
States / cities: Fairhope, Alabama • Homewood, Alabama • Huntsville, Alabama + 61 more

Conditions: Erectile Dysfunction
Interventions: Vardenafil ODT, (Staxyn, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 65 Years to 80 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 2
States / cities: Miami, Florida • Knoxville, Tennessee

Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
Interventions: PDE5 Inhibitors; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 44
States / cities: Birmingham, Alabama • Los Altos, California • National City, California + 40 more

Conditions: Erectile Dysfunction
Interventions: Vardenafil ODT (STAXYN, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 21
States / cities: Chandler, Arizona • Mesa, Arizona • Phoenix, Arizona + 15 more

Conditions: Erectile Dysfunction
Interventions: Levitra (Vardenafil, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 732 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003
U.S. locations: 12
States / cities: Phoenix, Arizona • Beverly Hills, California • San Bernardino, California + 9 more

Conditions: Erectile Dysfunction
Interventions: Levitra (Vardenafil, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 18
States / cities: Phoenix, Arizona • Beverly Hills, California • Irvine, California + 14 more

Conditions: Erectile Dysfunction, Depression
Interventions: Levitra (Vardenafil, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 15
States / cities: Huntsville, Alabama • Anchorage, Alaska • Beverly Hills, California + 11 more

Conditions: Erectile Dysfunction, Sexual Dysfunction
Interventions: Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor); Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 495 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 19
States / cities: Decatur, Alabama • Huntsville, Alabama • Englewood, Colorado + 16 more

Conditions: Ischemia-reperfusion Injury.
Interventions: Vardenafil; Drug
Lead sponsor: McGuire Research Institute; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Anterior Ischemic Optic Neuropathy
Interventions: Diagnostic procedures; Drug
Lead sponsor: Bayer; Industry
Eligibility: 40 Years and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 11
States / cities: Vista, California • Atlantis, Florida • Fort Myers, Florida + 7 more

Search by objective public record fields.

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function

Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)

Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia

Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study

A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.

A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction

Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction

Depression Related Improvement With Vardenafil for Erectile Response

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction

The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)